Yuani Yellson

PHD Doctor of Philosophy,  Massachusetts General Hospital 

Location: India

Consulting Services

Career Advice and Mentoring Journal Manuscript

Areas Of Interest

Questionnaires Procedure, Otologic Surgical Adrenergic beta 1 Receptor Antagonists Pulse Wave Analysis Methacrylic Acid Polymers Dehydratase, L-Serine CDP-DG Inositol Transferase Pharmacy Residencies Immunoglobulins, Human Intravenous D Galactoside Binding Lectin SH2 Domain Containing Protein Tyrosine Phosphatases Sensitivity Training Groups Writers Cramp Granulocyte Progenitors Bronchopulmonary Allergic Aspergillosis Spindle Apparatus, Meiotic Spasticity, Clasp-Knife Double Stranded RNA Binding Domain Interleukin 8 Phenomena, Psychological Mesoderm, Intermediate Pyrrolidines Relation, Doctor Patient Vitamin K-Dependent Bone Protein HEK 293 Cells Encephalitozoonoses Staff, Medical Behaviors, Stereotyped D Amino Acid Oxidase Pterygium Infected Hydronephrosis Product, Nicotine Replacement White Fat Cells

Professional Narrative

Dr. Yuani Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Assistant Professor, Amgen 2004
Executive Director, Mayo Clinic 2004

Education

Doctor of osteopathic medicine, Baylor College 2012
Doctor of medicine, Yale School of Medicine 2017

Referees

Publications

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02